End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28,700 KRW | -7.12% |
|
-10.03% | -36.92% |
Business Summary
Number of employees: 769
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sample Service Consignment
50.2
%
| 161,428 | 68.4 % | 94,194 | 50.2 % | -41.65% |
Anticancer Immunotherapy
18.6
%
| 30,671 | 13.0 % | 34,938 | 18.6 % | +13.91% |
Biologistics
13.8
%
| 19,237 | 8.1 % | 25,823 | 13.8 % | +34.23% |
Cell Therapy
7.4
%
| 6,584 | 2.8 % | 13,795 | 7.4 % | +109.52% |
Product
4.5
%
| 7,264 | 3.1 % | 8,397 | 4.5 % | +15.59% |
CDMO
3.0
%
| 7,685 | 3.3 % | 5,712 | 3.0 % | -25.67% |
Cell Storage
1.3
%
| 1,936 | 0.8 % | 2,509 | 1.3 % | +29.55% |
Others
1.2
%
| 1,314 | 0.6 % | 2,177 | 1.2 % | +65.70% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
88.1
%
| 219,412 | 92.9 % | 165,214 | 88.1 % | -24.70% |
United States
10.7
%
| 13,717 | 5.8 % | 20,125 | 10.7 % | +46.72% |
Japan
0.8
%
| 1,257 | 0.5 % | 1,538 | 0.8 % | +22.35% |
Others
0.4
%
| 1,734 | 0.7 % | 667 | 0.4 % | -61.55% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Park
CEO | Chief Executive Officer | 58 | 28/23/28 |
Jong-Seong Ahn
CTO | Chief Tech/Sci/R&D Officer | 59 | - |
Pil-Seok Seong
BRD | Director/Board Member | 58 | - |
Yu-Kyeong Hwang
BRD | Director/Board Member | 58 | 01/14/01 |
Seong-Il Hong
SAM | Sales & Marketing | 60 | - |
Nam-Chul Seo
AUD | Comptroller/Controller/Auditor | 61 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yu-Kyeong Hwang
BRD | Director/Board Member | 58 | 01/14/01 |
Ho-Won Kim
BRD | Director/Board Member | 66 | 28/23/28 |
Dae-Hee Lee
BRD | Director/Board Member | 56 | 01/15/01 |
Pil-Seok Seong
BRD | Director/Board Member | 58 | - |
James Park
CEO | Chief Executive Officer | 58 | 28/23/28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 15,800,344 | 8,281,318 ( 52.41 %) | 773,203 ( 4.894 %) | 52.41 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
GC CELL CORPORATION 4.92% | 777,703 | 4.92% | 19,041,661 $ |
Company contact information
![address GC Cell Corporation(A144510)](https://cdn.zonebourse.com/static/address/34430269.png)
Sector
Sales per Business
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-36.92% | 310M | |
+67.16% | 4.29B | |
+6.70% | 2.73B | |
-2.10% | 2.62B | |
-53.68% | 1.85B | |
-17.92% | 1.7B | |
-20.18% | 1.43B | |
+15.80% | 1.19B | |
-47.67% | 1.06B | |
+11.91% | 932M |
- Stock Market
- Equities
- A144510 Stock
- Company GC Cell Corporation